PATENT CLAIM ANALYSIS

Application Number: 15860200
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "139100"]

Abstract:
The present invention provides isolated human or humanized antibodies or antigen-binding fragments thereof which specifically bind to Growth and Differentiation Factor-8 (GDF8) and block GDF8 activity. The antibodies and antibody fragments of the present invention may be used in therapeutic methods for treating conditions or disorders which are ameliorated or improved by inhibition of GDF8.

Claim (Index 28):
The antibody or antigen-binding fragment of  claim 26 , wherein the antibody or antigen-binding fragment does not bind to or block the biological activity of a chimeric GDF8/TGF\u03b21 construct having amino acids 48-72 of mature human GDF8 replaced with the corresponding amino acid sequence of TGF\u03b21.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.34091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14974147', '13115170', '14462085', '15637867', '14447444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8134056004637846
- 35 USC 102 Novelty (BERT): 0.6665809487456681
- Combined Prediction Score: 0.798723135291973
- Mean Citation Score: 629.0445040000002
- Max Citation Score: 750.4044
- Similarity Product: 607.4592341043949

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test